Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2026-01-05 @ 6:26 PM
Study NCT ID:
NCT00023335
Status:
COMPLETED
Last Update Posted:
2005-09-05
First Post:
2001-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
Sponsor:
Centers for Disease Control and Prevention
Organization:
Organization Data
Organization:
Class:
FED
Study ID:
CDC-NCHSTP-1427
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
FED
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |